Global Dengue Vaccines Market 2018-2024: Opportunities, Future Trends, Growing Demand, Analysis, Forecast & Industry Developments

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Sep-2018   |    Format :PDF   |    Number of Pages : 114
This report studies the global market size of Dengue Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dengue Vaccines in these regions.
This research report categorizes the global Dengue Vaccines market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Dengue Vaccines market size was  million US$ and is forecast to  million US in 2025, growing at a CAGR of  from 2018. The objectives of this study are to define, segment, and project the size of the Dengue Vaccines market based on company, product type, application and key regions.

The various contributors involved in the value chain of Dengue Vaccines include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Dengue Vaccines include
    Sanofi
    Takeda Pharmaceutical

Market Size Split by Type
    CYD-TDV
    Tak-003
    Other
Market Size Split by Application
    Hospitals
    Government Institutes
    Non-Governmental Organizations (NGOs)

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Dengue Vaccines market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Dengue Vaccines market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Dengue Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Dengue Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Dengue Vaccines submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Dengue Vaccines are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dengue Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage
    1.1  Dengue Vaccines Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Dengue Vaccines Market Size Growth Rate by Type
        1.4.2 CYD-TDV
        1.4.3 Tak-003
        1.4.4 Other
    1.5 Market by Application
        1.5.1 Global Dengue Vaccines Market Size Growth Rate by Application
        1.5.2 Hospitals
        1.5.3 Government Institutes
        1.5.4 Non-Governmental Organizations (NGOs)
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Dengue Vaccines Market Size
        2.1.1 Global Dengue Vaccines Revenue 2016-2025
        2.1.2 Global Dengue Vaccines Sales 2016-2025
    2.2 Dengue Vaccines Growth Rate by Regions
        2.2.1 Global Dengue Vaccines Sales by Regions
        2.2.2 Global Dengue Vaccines Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Dengue Vaccines Sales by Manufacturers
        3.1.1 Dengue Vaccines Sales by Manufacturers
        3.1.2 Dengue Vaccines Sales Market Share by Manufacturers
        3.1.3 Global Dengue Vaccines Market Concentration Ratio (CR5 and HHI)
    3.2 Dengue Vaccines Revenue by Manufacturers
        3.2.1 Dengue Vaccines Revenue by Manufacturers (2016-2018)
        3.2.2 Dengue Vaccines Revenue Share by Manufacturers (2016-2018)
    3.3 Dengue Vaccines Price by Manufacturers
    3.4 Dengue Vaccines Manufacturing Base Distribution, Product Types
        3.4.1 Dengue Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Dengue Vaccines Product Category
        3.4.3 Date of International Manufacturers Enter into Dengue Vaccines  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Dengue Vaccines Sales by Type
    4.2 Global Dengue Vaccines Revenue by Type
    4.3 Dengue Vaccines Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Dengue Vaccines Breakdown Data by Application

6 North America
    6.1 North America Dengue Vaccines by Countries
        6.1.1 North America Dengue Vaccines Sales by Countries
        6.1.2 North America Dengue Vaccines Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Dengue Vaccines by Type
    6.3 North America Dengue Vaccines by Application
    6.4 North America Dengue Vaccines by Company

7 Europe
    7.1 Europe Dengue Vaccines by Countries
        7.1.1 Europe Dengue Vaccines Sales by Countries
        7.1.2 Europe Dengue Vaccines Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Dengue Vaccines by Type
    7.3 Europe Dengue Vaccines by Application
    7.4 Europe Dengue Vaccines by Company

8 Asia Pacific
    8.1 Asia Pacific Dengue Vaccines by Countries
        8.1.1 Asia Pacific Dengue Vaccines Sales by Countries
        8.1.2 Asia Pacific Dengue Vaccines Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Dengue Vaccines by Type
    8.3 Asia Pacific Dengue Vaccines by Application
    8.4 Asia Pacific Dengue Vaccines by Company

9 Central & South America
    9.1 Central & South America Dengue Vaccines by Countries
        9.1.1 Central & South America Dengue Vaccines Sales by Countries
        9.1.2 Central & South America Dengue Vaccines Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Dengue Vaccines by Type
    9.3 Central & South America Dengue Vaccines by Application
    9.4 Central & South America Dengue Vaccines by Company

10 Middle East and Africa
    10.1 Middle East and Africa Dengue Vaccines by Countries
        10.1.1 Middle East and Africa Dengue Vaccines Sales by Countries
        10.1.2 Middle East and Africa Dengue Vaccines Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Dengue Vaccines by Type
    10.3 Middle East and Africa Dengue Vaccines by Application
    10.4 Middle East and Africa Dengue Vaccines by Company

11 Company Profiles
    11.1 Sanofi
        11.1.1 Sanofi Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Dengue Vaccines
        11.1.4 Dengue Vaccines Product Description
        11.1.5 Recent Development
    11.2 Takeda Pharmaceutical
        11.2.1 Takeda Pharmaceutical Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Dengue Vaccines
        11.2.4 Dengue Vaccines Product Description
        11.2.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Dengue Vaccines Raw Material
        13.1.2 Dengue Vaccines Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer



List of Tables and Figures

    Figure Picture of Dengue Vaccines
    Figure Global Dengue Vaccines Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Dengue Vaccines Production Market Share by Types (Product Category) in 2017
    Figure CYD-TDV Product Picture
    Table Major Manufacturers of CYD-TDV
    Figure Tak-003 Product Picture
    Table Major Manufacturers of Tak-003
    Figure Other Product Picture
    Table Major Manufacturers of Other
    Table Global Dengue Vaccines Market Size Growth Rate by Application 2018-2025 (K Pcs)
    Figure Hospitals
    Figure Government Institutes
    Figure Non-Governmental Organizations (NGOs)
    Figure Dengue Vaccines Report Years Considered
    Figure Global Dengue Vaccines Market Size 2016-2025 (Million US$)
    Figure Global Dengue Vaccines Sales 2016-2025 (K Pcs)
    Table Global Dengue Vaccines Market Size by Regions 2016-2025 (K Pcs) & (Million US$)
    Table Global Dengue Vaccines Sales by Regions 2016-2025 (K Pcs)
    Table Global Dengue Vaccines Sales Market Share by Regions 2016-2025
    Figure Global Dengue Vaccines Sales Market Share by Regions 2016-2025
    Figure 2017 Global Dengue Vaccines Sales Market Share by Regions
    Table Global Dengue Vaccines Revenue by Regions 2016-2025 (Million US$)
    Table Global Dengue Vaccines Revenue Market Share by Regions 2016-2025
    Figure Global Dengue Vaccines Revenue Market Share by Regions 2016-2025
    Figure 2017 Global Dengue Vaccines Revenue Market Share by Regions
    Table Global Dengue Vaccines Sales by Manufacturers (2016-2018) (K Pcs)
    Table Global Dengue Vaccines Sales Share by Manufacturers (2016-2018)
    Figure Global Dengue Vaccines Sales Share by Manufacturers in 2017
    Table Dengue Vaccines Revenue by Manufacturers (2016-2018) (Million US$)
    Table Dengue Vaccines Revenue Share by Manufacturers (2016-2018)
    Figure Dengue Vaccines Value Share by Manufacturers in 2017
    Table Global Dengue Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Dengue Vaccines Price (2016-2018) (USD/Pcs)
    Table Dengue Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Dengue Vaccines Product Category
    Table Date of International Manufacturers Enter into Dengue Vaccines Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Dengue Vaccines Sales by Type (2016-2025) (K Pcs)
    Table Global Dengue Vaccines Sales Share by Type (2016-2025)
    Figure Global Dengue Vaccines Sales Market Share by Type (2016-2025)
    Figure Global Dengue Vaccines Sales Market Share by Type in 2017
    Table Global Dengue Vaccines Revenue by Type (2016-2025) (Million US$)
    Table Global Dengue Vaccines Revenue Share by Type (2016-2025)
    Figure Global Dengue Vaccines Revenue Market Share by Type (2016-2025)
    Figure Global Dengue Vaccines Revenue Market Share by Type in 2017
    Table Dengue Vaccines Price by Type 2013-2018 (USD/Pcs)
    Table Global Dengue Vaccines Sales by Application (2016-2025) (K Pcs)
    Table Global Dengue Vaccines Sales Share by Application (2016-2025)
    Figure Global Sales Dengue Vaccines Market Share by Application (2016-2025)
    Figure Global Sales Dengue Vaccines Market Share by Application (2016-2025)
    Figure North America Dengue Vaccines Sales Growth Rate 2016-2025 (K Pcs)
    Figure North America Dengue Vaccines Revenue Growth Rate 2016-2025 (Million US$)
    Table North America Dengue Vaccines Sales by Countries (2016-2025) (K Pcs)
    Table North America Dengue Vaccines Sales Market Share by Countries (2016-2025)
    Figure 2017 North America Dengue Vaccines Sales Market Share by Countries
    Table North America Dengue Vaccines Revenue by Countries (2016-2025) (Million US$)
    Table North America Dengue Vaccines Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America Dengue Vaccines Revenue Market Share by Countries
    Figure United States Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure United States Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure Canada Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure Mexico Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Table North America Dengue Vaccines Sales by Type (2016-2025) (K Pcs)
    Table North America Dengue Vaccines Sales Market Share by Type (2016-2025)
    Figure 2017 North America Dengue Vaccines Market Share by Type
    Table North America Dengue Vaccines Sales by Application (2016-2025) (K Pcs)
    Table North America Dengue Vaccines Sales Market Share by Application (2016-2025)
    Figure 2017 North America Dengue Vaccines Market Share by Application
    Table North America Dengue Vaccines Sales by Company (2016-2018) (K Pcs)
    Table North America Dengue Vaccines Sales Market Share by Company (2016-2018)
    Figure North America Dengue Vaccines Sales Market Share by Company in 2017
    Figure Europe Dengue Vaccines Sales Growth Rate 2016-2025 (K Pcs)
    Figure Europe Dengue Vaccines Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe Dengue Vaccines Sales by Countries (2016-2025) (K Pcs)
    Table Europe Dengue Vaccines Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe Dengue Vaccines Sales Market Share by Countries
    Table Europe Dengue Vaccines Revenue by Countries (2016-2025) (Million US$)
    Table Europe Dengue Vaccines Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe Dengue Vaccines Revenue Market Share by Countries
    Figure Germany Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure Germany Dengue Vaccines Revenue Growth Rate (2016-2025) (K Pcs)
    Figure France Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure France Dengue Vaccines Revenue Growth Rate (2016-2025) (K Pcs)
    Figure UK Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure UK Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure Italy Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure Russia Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe Dengue Vaccines Sales by Type (2016-2025) (K Pcs)
    Table Europe Dengue Vaccines Sales Market Share by Type (2016-2025)
    Figure 2017 Europe Dengue Vaccines Market Share by Type
    Table Europe Dengue Vaccines Sales by Application (2016-2025) (K Pcs)
    Table Europe Dengue Vaccines Sales Market Share by Application (2016-2025)
    Figure 2017 Europe Dengue Vaccines Market Share by Application
    Table Europe Dengue Vaccines Sales by Company (2016-2018) (K Pcs)
    Table Europe Dengue Vaccines Sales Market Share by Company (2016-2018)
    Figure Europe Dengue Vaccines Sales Market Share by Company in 2017
    Figure Asia Pacific Dengue Vaccines Sales Growth Rate 2016-2025 (K Pcs)
    Figure Asia Pacific Dengue Vaccines Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific Dengue Vaccines Sales by Countries (2016-2025) (K Pcs)
    Table Asia Pacific Dengue Vaccines Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Dengue Vaccines Sales Market Share by Countries
    Table Asia Pacific Dengue Vaccines Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific Dengue Vaccines Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Dengue Vaccines Revenue Market Share by Countries
    Figure China Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure China Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure Japan Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure Korea Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure India Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure India Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure Australia Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure Indonesia Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure Malaysia Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure Philippines Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure Thailand Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure Vietnam Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure Singapore Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific Dengue Vaccines Sales by Type (2016-2025) (K Pcs)
    Table Asia Pacific Dengue Vaccines Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific Dengue Vaccines Market Share by Type
    Table Asia Pacific Dengue Vaccines Sales by Application (2016-2025) (K Pcs)
    Table Asia Pacific Dengue Vaccines Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific Dengue Vaccines Market Share by Application
    Table Asia Pacific Dengue Vaccines Sales by Company (2016-2018) (K Pcs)
    Table Asia Pacific Dengue Vaccines Sales Market Share by Company (2016-2018)
    Figure Asia Pacific Dengue Vaccines Sales Market Share by Company in 2017
    Figure Central & South America Dengue Vaccines Sales Growth Rate 2016-2025 (K Pcs)
    Figure Central & South America Dengue Vaccines Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America Dengue Vaccines Sales by Countries (2016-2025) (K Pcs)
    Table Central & South America Dengue Vaccines Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Dengue Vaccines Sales Market Share by Countries
    Table Central & South America Dengue Vaccines Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America Dengue Vaccines Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Dengue Vaccines Revenue Market Share by Countries
    Figure Brazil Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure Brazil Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure Argentina Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America Dengue Vaccines Sales by Type (2016-2025) (K Pcs)
    Table Central & South America Dengue Vaccines Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America Dengue Vaccines Market Share by Type
    Table Central & South America Dengue Vaccines Sales by Application (2016-2025) (K Pcs)
    Table Central & South America Dengue Vaccines Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America Dengue Vaccines Market Share by Application
    Table Central & South America Dengue Vaccines Sales by Company (2016-2018) (K Pcs)
    Table Central & South America Dengue Vaccines Sales Market Share by Company (2016-2018)
    Figure Central & South America Dengue Vaccines Sales Market Share by Company in 2017
    Figure Middle East and Africa Dengue Vaccines Sales Growth Rate 2016-2025 (K Pcs)
    Figure Middle East and Africa Dengue Vaccines Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa Dengue Vaccines Sales by Countries (2016-2025) (K Pcs)
    Table Middle East and Africa Dengue Vaccines Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Dengue Vaccines Sales Market Share by Countries
    Table Middle East and Africa Dengue Vaccines Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa Dengue Vaccines Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Dengue Vaccines Revenue Market Share by Countries
    Figure GCC Countries Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure GCC Countries Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure Turkey Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure Egypt Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa Dengue Vaccines Sales Growth Rate (2016-2025) (K Pcs)
    Figure South Africa Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa Dengue Vaccines Sales by Type (2016-2025) (K Pcs)
    Table Middle East and Africa Dengue Vaccines Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa Dengue Vaccines Market Share by Type
    Table Middle East and Africa Dengue Vaccines Sales by Application (2016-2025) (K Pcs)
    Table Middle East and Africa Dengue Vaccines Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa Dengue Vaccines Market Share by Application
    Table Middle East and Africa Dengue Vaccines Sales by Company (2016-2018) (K Pcs)
    Table Middle East and Africa Dengue Vaccines Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa Dengue Vaccines Sales Market Share by Company in 2017
    Table Sanofi Company Details
    Table Sanofi Dengue Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
    Table Sanofi Recent Development
    Table Takeda Pharmaceutical Company Details
    Table Takeda Pharmaceutical Dengue Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
    Table Takeda Pharmaceutical Recent Development
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table Dengue Vaccines Value Chain
    Table Typical Suppliers of Key Dengue Vaccines Raw Material
    Table Dengue Vaccines Customers List
    Table Dengue Vaccines Sales Channels
    Table Dengue Vaccines Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

11-Aug-2018 | Electrical & Electronic Device

Samsung leads the pack, Smartphone Market in India Grows 29% In Third Quarter

The shipments of mobile in India are expected to reach the mark of 262 Million units till the fourth quarter arrives. Relying on the numbers, vendors dealing in mobile shipped approximately 80 Mill ...

18-Jul-2018 | Chemicals & Materials

It is Possible!! Can News Reports Be Automated?

Artificial intelligence is currently the hot topic of the town owing to its efficiency and quick work. It is a technology that is currently being used for a number of applications in the various se ...

26-Jun-2018 | Electrical & Electronic Device

Vodafone to Make Stronger Enterprise Portfolio Thus Bolstering Global Telecom Market

Vodafone India is seeking at the broadband segment to fortify its venture portfolio, said the Sunil Sood, the MD and CEO of the telecom company. The carriers had posted 2x development in the enterp ...

17-Apr-2018 | Food Service & Hospitality

Beneficiaries In Puducherry Don’t Use Subsidy To Purchase Food Grain

The Union Food Ministry has received a request from the administration of Puducherry for crediting the subsidy to the beneficiaries’ bank accounts rather than the system distributing subsidiz ...

22-Mar-2018 | Service

Indian SMEs Can Now Opt For WhatsApp Business App For Better Connectivity

WhatsApp, a “Facebook” owned mobile-based application, has introduced its innovative and efficient feature “WhatsApp Business App” ...